Neola Medical AB has been granted a patent in Europe for a technical method and equipment that enhance the accuracy of continuous measurements performed by the company’s medical device for lung monitoring, Neola®. This patent extends the protection for Neola® and strengthens the product’s competitiveness.
"The granting of this patent is a milestone in our intellectual property strategy, reinforcing our competitive edge in the market. By continuously expanding the protection of our product, we ensure that Neola® remains at the forefront of medical technology for neonatal care.", says CEO Hanna Sjöström.
The patent, now granted in Europe and previously granted in Sweden by the Swedish Patent and Registration Office, protects the company’s invention for compensating background signals, thereby improving the accuracy of measurements in the company’s product for continuous lung monitoring of preterm born infants.
The patent application is pending in the USA and China.